CANC logo

CANC Overview

Profile

Name:

Tema Oncology ETF

Assets under management:

$48 M

Expense ratio:

0.75%

Inception date:

August 14, 2023

Website:

-

Last ex-dividend date:

December 11, 2024

Next ex-dividend date:

N/A

Description:

CANC ETF is an exchange-traded fund that focuses on companies involved in cancer research and treatment. It aims to provide investors with exposure to the growing healthcare sector, particularly in oncology, by investing in stocks of firms developing innovative cancer therapies and technologies.

Top holdings

Name
Weight
ASTRAZENECA PLC(AZN.L)
5.60 %
LLY logo
Eli Lilly and Company(LLY)
5.35 %
BBIO logo
BridgeBio Pharma(BBIO)
5.17 %
MRK logo
Merck & Co(MRK)
4.17 %
RVMD logo
Revolution Medicines(RVMD)
3.99 %
GMAB logo
Genmab A/S(GMAB)
3.90 %
BeiGene(ONC)
3.86 %
ROCHE HOLDING AG(RHHBY)
3.85 %
EXEL logo
Exelixis(EXEL)
3.83 %
BMY logo
Bristol-Myers Squibb(BMY)
3.72 %
NOVARTIS AG(NOVN.SW)
3.54 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.37 %
AMGN logo
Amgen(AMGN)
3.18 %
NUVL logo
Nuvalent(NUVL)
3.05 %
LEGN logo
Legend Biotech(LEGN)
3.00 %
SMMT logo
Summit Therapeutics(SMMT)
2.83 %
DAIICHI SANKYO CO., LTD.(4568.T)
2.70 %
MRUS logo
Merus NV(MRUS)
2.59 %
BPMC logo
Blueprint Medicines(BPMC)
2.00 %
GILD logo
Gilead Sciences(GILD)
1.98 %
ABBV logo
AbbVie(ABBV)
1.94 %
ACLX logo
Arcellx(ACLX)
1.80 %
DAWN logo
Day One Biopharmaceuticals(DAWN)
1.74 %
ARGX logo
argenx SE(ARGX)
1.65 %
IDYA logo
IDEAYA Biosciences(IDYA)
1.50 %
ZLAB logo
Zai Lab Limited(ZLAB)
1.49 %
JANX logo
Janux Therapeutics(JANX)
1.40 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.11 %
MREO logo
Mereo BioPharma(MREO)
1.09 %
INCY logo
Incyte(INCY)
1.06 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$25.39
CANC price is $25.39

Price All-time High

$29.96
CANC price is currently -15.25% below its historical high of $29.96

Price Most Recent Change

-0.29%
CANC price was down -0.29% on Feb 27, 2025

Price YTD Change

+4.46%
CANC price is up +4.46% since January 1st

Price 1-Year Change

-12.93%
CANC price is down -12.93% year-on-year

Price 3-Year Change

-
CANC price 3-year change is unknown

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.85
CANC beta is 0.85

200-day SMA

$27.31
CANC price is currently -7.04% below its 200-day simple moving average

14-day RSI

49.35
CANC 14-day relative strength index is 49.35

30-day Relative Volume

0.61
CANC 30-day relative volume is 0.61

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Last Paid Dividend

$0.73
CANC last dividend was $0.73 per share, with an ex-dividend date of December 11, 2024

TTM Dividend Per Share

$0.73
CANC TTM dividend per share is $0.73

TTM Dividend Per Share 1-Year Change

+388.46%
CANC TTM dividend per share is up +388.46% year-on-year

TTM Dividend Per Share 3-Year Change

-
CANC TTM dividend per share 3-year change is unknown

Dividend yield

TTM Dividend Yield

2.87%
CANC TTM dividend yield is 2.87%

TTM Dividend Yield 1-Year Change

+462.75%
CANC TTM dividend yield is up +462.75% year-on-year

Top holdings

Name
Weight
ASTRAZENECA PLC(AZN.L)
5.60 %
LLY logo
Eli Lilly and Company(LLY)
5.35 %
BBIO logo
BridgeBio Pharma(BBIO)
5.17 %
MRK logo
Merck & Co(MRK)
4.17 %
RVMD logo
Revolution Medicines(RVMD)
3.99 %
GMAB logo
Genmab A/S(GMAB)
3.90 %
BeiGene(ONC)
3.86 %
ROCHE HOLDING AG(RHHBY)
3.85 %
EXEL logo
Exelixis(EXEL)
3.83 %
BMY logo
Bristol-Myers Squibb(BMY)
3.72 %
NOVARTIS AG(NOVN.SW)
3.54 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.37 %
AMGN logo
Amgen(AMGN)
3.18 %
NUVL logo
Nuvalent(NUVL)
3.05 %
LEGN logo
Legend Biotech(LEGN)
3.00 %
SMMT logo
Summit Therapeutics(SMMT)
2.83 %
DAIICHI SANKYO CO., LTD.(4568.T)
2.70 %
MRUS logo
Merus NV(MRUS)
2.59 %
BPMC logo
Blueprint Medicines(BPMC)
2.00 %
GILD logo
Gilead Sciences(GILD)
1.98 %
ABBV logo
AbbVie(ABBV)
1.94 %
ACLX logo
Arcellx(ACLX)
1.80 %
DAWN logo
Day One Biopharmaceuticals(DAWN)
1.74 %
ARGX logo
argenx SE(ARGX)
1.65 %
IDYA logo
IDEAYA Biosciences(IDYA)
1.50 %
ZLAB logo
Zai Lab Limited(ZLAB)
1.49 %
JANX logo
Janux Therapeutics(JANX)
1.40 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.11 %
MREO logo
Mereo BioPharma(MREO)
1.09 %
INCY logo
Incyte(INCY)
1.06 %

Analyst ratings

FAQ

  • What is CANC?
  • Does CANC pay dividends?
  • What stocks are in CANC?
  • What is the current assets under management for CANC?
  • What is CANC average volume?
  • What is CANC expense ratio?
  • What is CANC inception date?

What is CANC?

CANC ETF is an exchange-traded fund that focuses on companies involved in cancer research and treatment. It aims to provide investors with exposure to the growing healthcare sector, particularly in oncology, by investing in stocks of firms developing innovative cancer therapies and technologies.

Does CANC pay dividends?

Yes, the Tema Oncology ETF does pays dividends, with the most recent payment being $0.73 per share. The last ex-dividend date was on December 11, 2024, and the next ex-dividend date has not been announced yet

What stocks are in CANC?

As of today, Tema Oncology ETF inlcudes 52 holdings, with 46 of them being companies from 8 different countries and 1 sectors. The most weighted holdings are ASTRAZENECA PLC (5.6%), Eli Lilly and Company (5.35%) and BridgeBio Pharma (5.17%)

What is the current assets under management for CANC?

Assets under management of Tema Oncology ETF is $48 M

What is CANC average volume?

Average volume of Tema Oncology ETF is $20 K

What is CANC expense ratio?

Expense ratio of Tema Oncology ETF is 0.75%

What is CANC inception date?

Inception date of Tema Oncology ETF is August 14, 2023